Email not displaying correctly? View it in your browser
maCROscope logo Newsletter, Issue No 2, May 2016
KCR Announces Its BMX Days!
BIOMETRICS & CLINICAL DATA EXECUTION (BMX) DAYS: MAY – JUNE 2016
sign

IT’S ALL ABOUT THE QUALITY OF DATA

KCR announces its Biometrics and Clinical Data Execution (BMX) Days, which will be taking place during the upcoming weeks in May and June. We would like to introduce our clients and partners to KCR’s BMX services and to demonstrate the benefits when working with the company’s experts on quality data delivery.

More arrow
WE PUT OUR PROMISE INTO PRACTICE: DATA MANAGEMENT
sign

CASE STUDY: CONDUCT PROCESS

The conduct process at KCR ensures accurate prediction, prevention and dependable reaction on the data collected within a timely manner.

More (PDF) arrow
sign

CASE STUDY: CLOSE-OUT PROCESS

KCR’s close-out process is designed to maximize efficiency of Database Lock (DBL) activities and to ensure all DBL milestones are met.

More (PDF) arrow
sign

CASE STUDY: START-UP PROCESS

Start-up process at KCR is designed to set up the Electronic Data Capture (EDC) tool within a maximum of 12 weeks.

More (PDF) arrow
INTERVIEW WITH KCR’S HEAD OF BMX
sign

JOETTE KEEN ON DATA MANAGEMENT IN THE EVER-CHANGING CLINICAL TRIALS WORLD

JOETTE KEEN ON DATA MANAGEMENT IN THE EVER-CHANGING CLINICAL TRIALS WORLD

Joette Keen talks about her transition to CRO, after spending years in pharma, and how does she see data management role in the ever-changing clinical trials world.

More arrow
OUR KNOWLEDGE
sign

PASS – IS THE ONGOING SURVEILLANCE A BLESSING OR A CURSE?

PASS – IS THE ONGOING SURVEILLANCE A BLESSING OR A CURSE?

Increasing significance of Post-authorization safety studies (PASS) was one of the topics at the recent DIA EuroMeeting 2016, which took place on 6-8 of April in Hamburg. Magdalena Matusiak, Pharmacovigilance Team Lead at contract research organization KCR, highlighted the direction of recent changes in the PASS concept during the presentation, which was a part of the Session entitled “Assessing the benefits and risks as the basis of the benefit-risk management.”

More arrow
sign

APPLIED CLINICAL TRIALS: EARLY PLANNING ASSURES BETTER OUTCOMES

Article for Applied Clinical Trials on Post-Authorization Safety Study (PASS) as a crucial part of drug development design by Magdalena Matusiak, KCR’s Pharmacovigilance Team Lead. 

More arrow
OUR STRATEGY
sign

KCR MOVES INTO A NEW OFFICE IN HUNGARY, BUDAPEST

KCR MOVES INTO A NEW OFFICE IN HUNGARY, BUDAPEST

KCR has recently moved into new premises in Budapest, Hungary. The new office is located in the main trade area of the Hungarian capital and is easily accessible for business partners.“The new location for our business in Budapest is another KCR move to benefit from the local presence in the region and the excellent setting in the market for conducting clinical trials,” said Mike Jagielski, President & CEO of KCR.

More arrow
J
sign

UPCOMING EVENTS

Meet KCR at the upcoming industry events and discuss how we can partner in your clinical trial project:

arrow

24-26 May / IATI Biomed 2016 / Tel Aviv / Israel / Request a meeting

arrow

3-7 June / 2016 ASCO Annual Meeting / Chicago / IL / US  / Request a meeting

arrow

6-9 June / 2016 BIO International Convention / San Fransisco / CA / US  / Request a meeting

arrow

8-10 June  / PCMG Annual Conference 2016 / Rome / Italy / Request a meeting

arrow

26-30 June / DIA 2016 52nd Annual Meeting / Philadelphia / PA / US / Request a meeting

Head Office
KCR CRO GmbH
Pergamon Palais
Am Kupfergraben 4-4a
10117 Berlin, Germany

www YouTube SlideShare LinkedIn
Contact us Unsubscribe
pills